MET exon 14 alterations in lung cancer: Exon skipping extends half-life Journal Article


Author: Drilon, A.
Article Title: MET exon 14 alterations in lung cancer: Exon skipping extends half-life
Abstract: MET exon 14 alterations are a diverse group of mutations, many of which disrupt splice acceptor or donor sites leading to exon 14 skipping, impaired receptor degradation, and oncogenic transformation. These alterations are clinically targetable with MET-directed therapy. ©2016 AACR.
Journal Title: Clinical Cancer Research
Volume: 22
Issue: 12
ISSN: 1078-0432
Publisher: American Association for Cancer Research  
Date Published: 2016-06-15
Start Page: 2832
End Page: 2834
Language: English
DOI: 10.1158/1078-0432.ccr-16-0229
PROVIDER: scopus
PMCID: PMC4911276
PUBMED: 27009743
DOI/URL:
Notes: Article -- Export Date: 1 July 2016 -- Source: Scopus
Altmetric Score
MSK Authors
  1. Alexander Edward Drilon
    136 Drilon